登记Id

PA448422

药物名称(英)

amprenavir

通用名称

"AMP","AMV","APV","VX-478"

商品名称

"Agenerase","Prozei","Vertex"

品牌组合

类型(英)

Drug

类型

药品

交叉引用

"BindingDB:577","Canadian Drugs Product Database:02243542","ChEBI:CHEBI:2684","Chemical Abstracts Service:161814-49-9","ChemSpider:58532","ClinicalTrials.gov:NCT00207948","DrugBank:DB00701","KEGG Compound:C08086","KEGG Drug:D00894","PubChem Compound:65016","PubChem Substance:46507537","PubChem Substance:7847958","Therapeutic Targets Database:DAP000170","URL:http://en.wikipedia.org/wiki/Amprenavir"

简化分子线性输入规范

CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N

键

InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1

剂量指南

No

外部词汇

"MeSH:C095108(amprenavir)","ATC:J05AE05(amprenavir)","UMLS:C0754188(Amprenavir)","RxNorm:228656(Amprenavir)","NDFRT:N0000148609(AMPRENAVIR)"

RxNorm 标识符

228656

ATC 标识符

J05AE05

化合物标识符

65016